These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 38534527)

  • 1. Three Milliliters of Peripheral Blood Is Sufficient for Preparing Liquid Platelet-Rich Fibrin (PRF): An In Vitro Study.
    Al-Maawi S; Dohle E; Sader R; Ghanaati S
    Bioengineering (Basel); 2024 Mar; 11(3):. PubMed ID: 38534527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biologization of Pcl-Mesh Using Platelet Rich Fibrin (Prf) Enhances Its Regenerative Potential In Vitro.
    Al-Maawi S; Dohle E; Lim J; Weigl P; Teoh SH; Sader R; Ghanaati S
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33671550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Standardized
    Al-Maawi S; Dohle E; Kretschmer W; Rutkowski J; Sader R; Ghanaati S
    Tissue Eng Part A; 2022 Apr; 28(7-8):353-365. PubMed ID: 34555949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved growth factor delivery and cellular activity using concentrated platelet-rich fibrin (C-PRF) when compared with traditional injectable (i-PRF) protocols.
    Fujioka-Kobayashi M; Katagiri H; Kono M; Schaller B; Zhang Y; Sculean A; Miron RJ
    Clin Oral Investig; 2020 Dec; 24(12):4373-4383. PubMed ID: 32382929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduction of relative centrifugal forces increases growth factor release within solid platelet-rich-fibrin (PRF)-based matrices: a proof of concept of LSCC (low speed centrifugation concept).
    El Bagdadi K; Kubesch A; Yu X; Al-Maawi S; Orlowska A; Dias A; Booms P; Dohle E; Sader R; Kirkpatrick CJ; Choukroun J; Ghanaati S
    Eur J Trauma Emerg Surg; 2019 Jun; 45(3):467-479. PubMed ID: 28324162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of the centrifuge characteristics and centrifugation protocols on the cells, growth factors, and fibrin architecture of a leukocyte- and platelet-rich fibrin (L-PRF) clot and membrane.
    Dohan Ehrenfest DM; Pinto NR; Pereda A; Jiménez P; Corso MD; Kang BS; Nally M; Lanata N; Wang HL; Quirynen M
    Platelets; 2018 Mar; 29(2):171-184. PubMed ID: 28437133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leukocytes within Autologous Blood Concentrates Have No Impact on the Growth and Proliferation of Human Primary Osteoblasts: An In Vitro Study.
    Mourão CF; Dohle E; Bayrak B; Winter A; Sader R; Ghanaati S
    Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38674127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction of relative centrifugation force within injectable platelet-rich-fibrin (PRF) concentrates advances patients' own inflammatory cells, platelets and growth factors: the first introduction to the low speed centrifugation concept.
    Choukroun J; Ghanaati S
    Eur J Trauma Emerg Surg; 2018 Feb; 44(1):87-95. PubMed ID: 28283682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biological characterization of an injectable platelet-rich fibrin mixture consisting of autologous albumin gel and liquid platelet-rich fibrin (Alb-PRF).
    Fujioka-Kobayashi M; Schaller B; Mourão CFAB; Zhang Y; Sculean A; Miron RJ
    Platelets; 2021 Jan; 32(1):74-81. PubMed ID: 31959025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduction of the relative centrifugal force influences cell number and growth factor release within injectable PRF-based matrices.
    Wend S; Kubesch A; Orlowska A; Al-Maawi S; Zender N; Dias A; Miron RJ; Sader R; Booms P; Kirkpatrick CJ; Choukroun J; Ghanaati S
    J Mater Sci Mater Med; 2017 Oct; 28(12):188. PubMed ID: 29071440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibrin clot and Leukocyte-rich platelet-rich fibrin show similar release kinetics and amount of growth factors: a pilot study.
    Nakanishi Y; Matsushita T; Nagai K; Araki D; Hoshino Y; Kuroda R
    J Orthop Surg Res; 2023 Mar; 18(1):238. PubMed ID: 36964579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet-rich concentrates differentially release growth factors and induce cell migration in vitro.
    Schär MO; Diaz-Romero J; Kohl S; Zumstein MA; Nesic D
    Clin Orthop Relat Res; 2015 May; 473(5):1635-43. PubMed ID: 25690170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimized Platelet-Rich Fibrin With the Low-Speed Concept: Growth Factor Release, Biocompatibility, and Cellular Response.
    Fujioka-Kobayashi M; Miron RJ; Hernandez M; Kandalam U; Zhang Y; Choukroun J
    J Periodontol; 2017 Jan; 88(1):112-121. PubMed ID: 27587367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth Factor Release within Liquid and Solid PRF.
    Zwittnig K; Kirnbauer B; Jakse N; Schlenke P; Mischak I; Ghanaati S; Al-Maawi S; Végh D; Payer M; Zrnc TA
    J Clin Med; 2022 Aug; 11(17):. PubMed ID: 36078998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Injectable platelet rich fibrin (i-PRF): opportunities in regenerative dentistry?
    Miron RJ; Fujioka-Kobayashi M; Hernandez M; Kandalam U; Zhang Y; Ghanaati S; Choukroun J
    Clin Oral Investig; 2017 Nov; 21(8):2619-2627. PubMed ID: 28154995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of platelet-rich fibrin (PRF) produced using 3 commercially available centrifuges at both high (~ 700 g) and low (~ 200 g) relative centrifugation forces.
    Miron RJ; Xu H; Chai J; Wang J; Zheng S; Feng M; Zhang X; Wei Y; Chen Y; Mourão CFAB; Sculean A; Zhang Y
    Clin Oral Investig; 2020 Mar; 24(3):1171-1182. PubMed ID: 31321574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A low-speed centrifugation concept leads to cell accumulation and vascularization of solid platelet-rich fibrin: an experimental study in vivo.
    Kubesch A; Barbeck M; Al-Maawi S; Orlowska A; Booms PF; Sader RA; Miron RJ; Kirkpatrick CJ; Choukroun J; Ghanaati S
    Platelets; 2019; 30(3):329-340. PubMed ID: 29509050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Injectable platelet rich fibrin: cell content, morphological, and protein characterization.
    Varela HA; Souza JCM; Nascimento RM; Araújo RF; Vasconcelos RC; Cavalcante RS; Guedes PM; Araújo AA
    Clin Oral Investig; 2019 Mar; 23(3):1309-1318. PubMed ID: 30003342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet rich fibrin as a bioactive matrix with proosteogenic and proangiogenic properties on human healthy primary cells in vitro.
    Dohle E; Schmeinck L; Parkhoo K; Sader R; Ghanaati S
    Platelets; 2024 Dec; 35(1):2316744. PubMed ID: 38390838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparative study of platelet-rich fibrin (PRF) and platelet-rich plasma (PRP) on the effect of proliferation and differentiation of rat osteoblasts in vitro.
    He L; Lin Y; Hu X; Zhang Y; Wu H
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 Nov; 108(5):707-13. PubMed ID: 19836723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.